Advertisement

Topics

Mizuho OSI Company Profile

01:03 EDT 22nd September 2018 | BioPortfolio

With over 35 years of experience designing and manufacturing specialty healthcare products, Mizuho OSI focuses on improving surgery through advanced patient positioning. Mizuho OSI offers a wide variety of highly specialized surgical tables for spinal and orthopedic trauma surgery, as well as tables for comprehensive imaging required for today’s minimally invasive procedures.


News Articles [15 Associated News Articles listed on BioPortfolio]

Cardinal Health (CAH) PT Set at $61.00 by Mizuho

The firm currently has a "hold" rating on the stock. Mizuho's price target would suggest a potential upside of 16.19% from the company's current price.

Mizuho Reiterates Buy Rating for Teva Pharmaceutical Industries

's stock had its "buy" rating reaffirmed by analysts at Mizuho in a research note issued to investors on Friday. They presently have a $27.00 price target on the stock.

Teva Pharmaceutical Industries (TEVA) Stock Rating Reaffirmed by Mizuho

's stock had its "hold" rating reiterated by Mizuho in a research note issued to investors on Monday, October 30th. They presently have a $15.00 price target on the stock.

Biogen-Aktie hat noch viel Luft nach oben!

New York (www.aktiencheck.de) - Biogen-Aktienanalyse des Analysten Salim Syed von Mizuho Securities USA: Salim Syed, Aktienanalyst von Mizuho Securities USA, spricht laut einer Aktienanalyse weiter...

Biogen-Aktie verliert übertrieben stark!

New York (www.aktiencheck.de) - Biogen-Aktienanalyse des Analysten Salim Syed von Mizuho Securities USA: Salim Syed, Aktienanalyst von Mizuho Securities USA, spricht laut einer Aktienanalyse weiter...

Amgen-Aktie: Konkurrenz durch Mylan!

New York (www.aktiencheck.de) - Amgen-Aktienanalyse des Analysten Salim Syed von Mizuho Securities USA: Salim Syed, Aktienanalyst von Mizuho Securities USA, spricht laut einer Aktienanalyse eine Ka...

TEVA Pharmaceutical: Nervosität war unbegründet!

New York (www.aktiencheck.de) - TEVA Pharmaceutical-Aktienanalyse der Analystin Irina Koffler von Mizuho Securities USA: Laut einer Aktienanalyse sprich Irina Koffler, Aktienanalystin bei Mizuho Se...

Apple-Aktie: Droht eine negative Überraschung?

New York - Apple-Aktienanalyse von Analyst Abhey Lamba von Mizuho Securities USA: Aktienanalyst Abhey Lamba von Mizuho Securities USA vertritt laut einer Aktienanalyse weiterhin eine neutrale Haltu...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

Mizuho OSI

With over 35 years of experience designing and manufacturing specialty healthcare products, Mizuho OSI focuses on improving surgery through advanced patient positioning. Mizuho OS...

More Information about "Mizuho OSI" on BioPortfolio

We have published hundreds of Mizuho OSI news stories on BioPortfolio along with dozens of Mizuho OSI Clinical Trials and PubMed Articles about Mizuho OSI for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Mizuho OSI Companies in our database. You can also find out about relevant Mizuho OSI Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...


Corporate Database Quicklinks



Searches Linking to this Company Record